Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00084305
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-28
First Post:
2004-06-09
Brief Title:
Analysis of Specimens From Individuals With Pulmonary Fibrosis
Sponsor:
National Human Genome Research Institute NHGRI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Analysis of Specimens From Individuals With Pulmonary Fibrosis
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-10-21
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The etiology of pulmonary fibrosis is unknown Analyses of blood genomic DNA and specimens procured by bronchoscopy lung biopsy lung transplantation clinically-indicated extra-pulmonary biopsies or post-mortem examination from individuals with this disorder may contribute to our understanding of the pathogenic mechanisms of pulmonary fibrosis The purpose of this protocol is to procure and analyze blood genomic DNA and specimens by bronchoscopy lung biopsy lung transplantation extra-pulmonary biopsies or post-mortem examination from subjects with pulmonary fibrosis In addition blood genomic DNA clinically-indicated extra-pulmonary biopsies as well as bronchoscopy and post-mortem examination specimens may be procured and analyzed from relatives of subjects with hereditary forms of pulmonary fibrosis blood genomic DNA and bronchoscopy specimens may be procured from healthy research volunteers
Detailed Description:
The etiology of pulmonary fibrosis is unknown Analyses of blood genomic DNA and specimens procured by bronchoscopy lung biopsy lung transplantation clinically-indicated extra-pulmonary biopsies or post-mortem examination from individuals with this disorder may contribute to our understanding of the pathogenic mechanisms of pulmonary fibrosis The purpose of this protocol is to procure and analyze blood genomic DNA and specimens by bronchoscopy lung biopsy lung transplantation extra-pulmonary biopsies or post-mortem examination from subjects with pulmonary fibrosis In addition blood genomic DNA clinically-indicated extra-pulmonary biopsies as well as bronchoscopy and post-mortem examination specimens may be procured and analyzed from relatives of subjects with hereditary forms of pulmonary fibrosis blood genomic DNA and bronchoscopy specimens may be procured from healthy research volunteers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 04-HG-0211 | None | None | None |